Foundation CEO Provides Expert Testimony to U.S. Senate as Outside Witness on Vision Research Funding
COLUMBIA, Md., June 13, 2025 /PRNewswire/ -- The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, today submitted written testimony to the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies through its chief executive officer, Jason Menzo, who served as an expert outside witness. In the testimony, Menzo urged the Subcommittee to deliver robust and sustained funding for the National Eye Institute (NEI) in Fiscal Year 2026 and to preserve NEI's status as an independent institute within the National Institutes of Health (NIH).
"NEI is the only federal institute dedicated exclusively to vision research," said Jason Menzo, CEO of the Foundation Fighting Blindness. "Its work is restoring sight, advancing precision medicine, and delivering hope to millions of Americans living with retinal diseases. Continued investment is critical to maintaining momentum and achieving breakthroughs for conditions that currently have no cure."
The Foundation's testimony highlights how NEI-supported research has led to transformative discoveries, including the first FDA-approved gene therapy for an inherited disease, and emphasizes NEI's strategic role in public-private collaborations that accelerate treatment development. The Foundation Fighting Blindness and NEI have long shared a close, collaborative partnership to advance high-impact scientific discovery and bring new treatments to patients faster. Vision loss from diseases such as retinitis pigmentosa, macular degeneration, and Stargardt disease currently affects tens of millions and costs the U.S. economy an estimated $134.2 billion annually.
The Foundation emphasized that inconsistent funding stalls clinical trials, closes labs, and risks losing top scientific talent—consequences that are difficult and costly to reverse. The testimony also noted that for every dollar invested in NIH-funded research, $2.56 in new economic activity is generated, making this one of the highest-return investments Congress can make.
"We're not just talking about restoring sight—we're talking about protecting America's leadership in biomedical innovation and supporting economic growth in communities nationwide," added Menzo.
The Foundation Fighting Blindness urges Congress to:
Provide strong, sustained funding for NEI in the FY2026 Labor-HHS Appropriations bill; and
Preserve NEI's status as an independent institute within NIH to ensure focused, strategic investment in vision science.
The full testimony is available at FightingBlindness.org.
About the Foundation Fighting BlindnessEstablished in 1971, the Foundation Fighting Blindness is the world's leading private source of funding for research on retinal degenerative diseases. The Foundation has raised over $954 million toward its mission to prevent, treat, and cure blinding diseases such as retinitis pigmentosa, age-related macular degeneration, Usher syndrome, and more. Visit FightingBlindness.org for more information.
Media Contacts:Chris AdamsVice President, Marketing & CommunicationsCAdams@FightingBlindness.org(410) 423-0585
View original content to download multimedia:https://www.prnewswire.com/news-releases/foundation-ceo-provides-expert-testimony-to-us-senate-as-outside-witness-on-vision-research-funding-302481562.html
SOURCE Foundation Fighting Blindness
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Novo Nordisk Shares Rise on U.S. Approval of Wegovy for Liver Disease
Novo Nordisk (NVO, Financials) shares climbed nearly 5% Monday after the U.S. Food and Drug Administration granted accelerated approval for its weight-loss drug Wegovy to treat metabolic dysfunction-associated steatohepatitis in adults with moderate to advanced liver fibrosis. Warning! GuruFocus has detected 1 Warning Sign with NVO. The approval makes Wegovy the first GLP-1 therapy cleared for MASH, a progressive liver condition affecting about 5% of U.S. adults, according to the American Liver Foundation. The drug was approved for use alongside a reduced-calorie diet and increased physical activity. Novo Nordisk said the decision was supported by the first phase of its ESSENCE trial, which showed Wegovy patients had statistically significant improvements in liver fibrosis compared to placebo. About 63% of participants receiving Wegovy achieved resolution of steatohepatitis without worsening fibrosis, compared with 34% in the placebo group. More than one-third of Wegovy patients also saw improvement in fibrosis without worsening steatohepatitis, versus 22% on placebo. The second phase of the trial is expected in 2029. The company said Wegovy is immediately available in the U.S. for MASH. The only other FDA-approved treatment for the disease is Madrigal Pharmaceuticals' (MDGL, Financials) Rezdiffra, cleared in 2024. Novo Nordisk shares were up 5.46% in London trading as of 10:43 a.m. This article first appeared on GuruFocus.
New York Post
an hour ago
- New York Post
FDA proposes way to cut sugar in orange juice without changing the taste
The U.S. Food and Drug Administration (FDA) is proposing an update to a decades-old orange juice rule that could give American citrus growers a boost — with little to no change in the taste of the popular breakfast staple, experts say. For the first time since 1963, the agency wants to lower the minimum sugar content required in pasteurized orange juice. Advertisement The proposal, announced on Aug. 6, would drop the required Brix level — a measure of dissolved solids, mostly natural sugars — from 10.5% to 10%. The shift aligns with the natural Brix levels now present in American oranges and corresponds to about 1 gram less of sugar per 8-ounce serving, from 18 grams to 17 grams, per the FDA. The change stems from a 2022 petition by the Florida Citrus Processors Association and Florida Citrus Mutual in which they said the average Brix level of Florida oranges was 9.7 in 2022–23. The current standard was established in 1963 when Florida oranges averaged 11.8 Brix. Severe weather and citrus greening disease have lowered Brix levels in fruit, forcing producers to import sweeter juice – often from Mexico and Brazil – to blend with theirs in order to meet federal standards, according to the FDA. Advertisement 4 The FDA is proposing an update to a decades-old orange juice rule that could give American citrus growers a boost — with little to no change in the taste of the popular breakfast staple, experts say. alter_photo – 'For years, we've been wasting beautiful American oranges simply due to an outdated regulation, while relying on a high volume of imports,' FDA Commissioner Marty Makary said in a statement. The change would reduce dependency on imports, potentially saving orange producers more than $50 million annually, the agency estimated. Growers could still make higher Brix juice if supplies allow, according to the FDA. Advertisement Uncle Matt's Organic, which makes a variety of juices, lemonades and iced teas, will not be lowering its Brix levels, co-founder Susan McLean said. 4 For the first time since 1963, the agency wants to lower the minimum sugar content required in pasteurized orange juice. Nitr – 'Uncle Matt's Organic orange juice contains no added sugar,' she told Fox News Digital. 'The naturally occurring sugar content comes directly from the fruit itself, and our Brix is consistently above 11.8, which is well above the minimum threshold.' But the Florida-based company supports the FDA's proposal. Advertisement 'The update will allow struggling growers to market their fruit more effectively without compromising transparency or food safety,' McLean said. The move is part of the FDA's review of over 250 Standards of Identity (SOIs), federally defined rules that spell out what certain foods must contain, and sometimes how they are made, in order to be marketed under a specific name. 'The agency is working to ensure its rules are science-based, relevant and responsive to today's food supply and consumer needs,' the FDA said in a statement. A public comment period on the proposed rule is open until Nov. 4. The FDA is also seeking feedback on whether to lower the Brix level further. Shannon Shepp, executive director of the Florida Department of Citrus, which has long supported the Brix adjustment, said the industry is not advocating for eliminating standards. 'We support science-based updates that reflect current growing conditions, while protecting Florida oranges, our growers and the future of Florida orange juice,' Shepp told Fox News Digital. 'These standards are created in a spirit of honesty, so that consumers know exactly what they are getting from properly labeled products.' Advertisement 4 'For years, we've been wasting beautiful American oranges simply due to an outdated regulation, while relying on a high volume of imports,' FDA Commissioner Marty Makary said in a statement. AP Bryan Quoc Le, a California food scientist and author of the book '150 Food Science Questions Answered,' told Fox News Digital the change in sugar content will not greatly alter the overall composition of the orange juice. 'There may be very minor changes in flavor profile, fiber content and other components that come along with orange juice, but ultimately this will not be particularly noticeable from either a health or an industry standpoint,' he added. The public health impact would be minimal, agreed Dr. Michael Ednie, a Florida-based doctor who is also a registered dietitian. Advertisement 4 The move is part of the FDA's review of over 250 Standards of Identity (SOIs), federally defined rules that spell out what certain foods must contain, and sometimes how they are made, in order to be marketed under a specific name. AP 'Orange juice has been criticized for its sugar content because drinking lots of sugary beverages – including fruit juices – can increase risks of health problems, like diabetes and tooth decay,' Ednie told Fox News Digital. Nutrition guidelines already recommend drinking fruit juice in moderation, he noted. 'So, the main message for public health stays the same: Orange juice is best enjoyed in reasonable amounts as part of a balanced diet.'
Newsweek
an hour ago
- Newsweek
BBQ Seasoning Recall as Consumer Risk Warning Issued
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A recall of various seasoning products due to potential contamination with foreign objects has received the second-highest risk warning by the Food and Drug Administration (FDA). QST Ingredients and Packaging issued a voluntary recall for four seasoning products on August 7 over the possible presence of metal fragments. On August 14, the FDA later issued a Class II risk classification for the recall. Newsweek contacted QST Ingredients and Packaging for comment by email and phone outside regular working hours. A stock image of a chef seasoning food. A stock image of a chef seasoning food. Sipa/AP Why It Matters A Class II risk classification, one of three, refers to a situation in which the "use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote," according to the FDA. Foreign material in food products presents health risks, including choking, damage to teeth and digestive tract injury. Small pieces of metal could obstruct airways, especially in vulnerable populations, such as children and older adults. What To Know The products affected by the recall include the following: BBQ Riblet Seasoning. UPC: QST# 5275. Lot numbers: 059251, 079251, 154251, 170251, 170252 Reduced Sodium Roast Beef Rub. UPC: QST# 6313. Lot numbers: 092251, 112251, 133251, 160251, 181251 Lemon Pepper Seasoning. UPC: QST# 6402. Lot number: 118251 Cajun Seasoning. UPC: QST# 4546. Lot number: 118251 A total of 19,731 pounds of each product were included in the recall, according to the FDA. They were distributed to California and Texas. The products were distributed to four different customers who either used them for further processing or repackaged them for retail sales, the FDA said. As of August 14, no illnesses or injuries had been reported in connection with the consumption of the recalled products. What People Are Saying Dr. Mark Fischer, the regional medical director at International SOS, previously told Newsweek: "It can be dangerous to consume metals or other foreign objects found in food. … [They] can cause cuts or internal injury and may need to be removed via a surgical procedure. If you swallow any foreign objects, it's best to consult a health care professional." Darin Detwiler, a professor of food policy at Northeastern University, previously told Newsweek: "While not as urgent as Class I recalls, Class II recalls should still be heeded, and the products should be returned or disposed of according to the instructions provided." What Happens Next The recall is listed as ongoing, according to the FDA. Consumers who purchased the affected products should not consume them.
